Study of tissue oxygen supply rate in a macroscopic photodynamic therapy singlet oxygen model

Abstract. An appropriate expression for the oxygen supply rate (Γs) is required for the macroscopic modeling of the complex mechanisms of photodynamic therapy (PDT). It is unrealistic to model the actual heterogeneous tumor microvascular networks coupled with the PDT processes because of the large computational requirement. In this study, a theoretical microscopic model based on uniformly distributed Krogh cylinders is used to calculate Γs=g (1−[O32]/[O32]0) that can replace the complex modeling of blood vasculature while maintaining a reasonable resemblance to reality; g is the maximum oxygen supply rate and [O32]/[O32]0 is the volume-average tissue oxygen concentration normalized to its value prior to PDT. The model incorporates kinetic equations of oxygen diffusion and convection within capillaries and oxygen saturation from oxyhemoglobin. Oxygen supply to the tissue is via diffusion from the uniformly distributed blood vessels. Oxygen can also diffuse along the radius and the longitudinal axis of the cylinder within tissue. The relations of Γs to [3O2]/[3O2]0 are examined for a biologically reasonable range of the physiological parameters for the microvasculature and several light fluence rates (ϕ). The results show a linear relationship between Γs and [3O2]/[3O2]0, independent of ϕ and photochemical parameters; the obtained g ranges from 0.4 to 1390  μM/s.

[1]  Jarod C Finlay,et al.  Macroscopic modeling of the singlet oxygen production during PDT , 2007, SPIE BiOS.

[2]  R. McMillon,et al.  Regulation of Tissue Oxygenation , 1995 .

[3]  Ken Kang-Hsin Wang,et al.  A comprehensive mathematical model of microscopic dose deposition in photodynamic therapy. , 2006, Medical physics.

[4]  M. Wiedeman,et al.  Dimensions of Blood Vessels from Distributing Artery to Collecting Vein , 1963, Circulation research.

[5]  C. Kieda,et al.  Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia , 2011, Journal of cellular and molecular medicine.

[6]  Michael S Patterson,et al.  In vitro tests of the validity of singlet oxygen luminescence measurements as a dose metric in photodynamic therapy. , 2003, Cancer research.

[7]  Guoqiang Yu,et al.  Increasing Damage to Tumor Blood Vessels during Motexafin Lutetium-PDT through Use of Low Fluence Rate , 2010, Radiation research.

[8]  Jarod C Finlay,et al.  Comparison of singlet oxygen threshold dose for PDT , 2014, Photonics West - Biomedical Optics.

[9]  Dai Fukumura,et al.  Scaling rules for diffusive drug delivery in tumor and normal tissues , 2011, Proceedings of the National Academy of Sciences.

[10]  H D Suit,et al.  Comparative morphometric study of tumor vasculature in human squamous cell carcinomas and their xenotransplants in athymic nude mice. , 1989, Cancer research.

[11]  Michael S Patterson,et al.  A dynamic model for ALA-PDT of skin: simulation of temporal and spatial distributions of ground-state oxygen, photosensitizer and singlet oxygen , 2010, Physics in medicine and biology.

[12]  Jarod C Finlay,et al.  Explicit dosimetry for photodynamic therapy: macroscopic singlet oxygen modeling , 2010, Journal of biophotonics.

[13]  David J Gavaghan,et al.  Mathematical modelling of oxygen transport to tissue , 2002, Journal of mathematical biology.

[14]  Jarod C Finlay,et al.  Photobleaching kinetics of Photofrin in vivo and in multicell tumour spheroids indicate two simultaneous bleaching mechanisms. , 2004, Physics in medicine and biology.

[15]  Arjun G Yodh,et al.  Correlation of in vivo photosensitizer fluorescence and photodynamic-therapy-induced depth of necrosis in a murine tumor model. , 2003, Journal of biomedical optics.

[16]  Thomas H. Foster,et al.  Integrated Spectroscopy and PDT Delivery for Various Treatment Geometries , 2008 .

[17]  T. Dougherty.  Photodynamic therapy. , 1993, Photochemistry and photobiology.

[18]  Thomas H Foster,et al.  In vivo confocal fluorescence imaging of the intratumor distribution of the photosensitizer mono-L-aspartylchlorin-e6. , 2008, Neoplasia.

[19]  Michael S Patterson,et al.  Direct Near-infrared Luminescence Detection of Singlet Oxygen Generated by Photodynamic Therapy in Cells In Vitro and Tissues In Vivo¶ , 2002, Photochemistry and photobiology.

[20]  Mukund Seshadri,et al.  Light Delivery over Extended Time Periods Enhances the Effectiveness of Photodynamic Therapy , 2008, Clinical Cancer Research.

[21]  Rui Hu,et al.  Intratumor administration of the photosensitizer pc 4 affords photodynamic therapy efficacy and selectivity at short drug-light intervals. , 2010, Translational oncology.

[22]  J D Murray,et al.  On the molecular mechanism of facilitated oxygen diffusion by haemoglobin and myoglobin , 1971, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[23]  Michael S Patterson,et al.  Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro , 2005, Physics in medicine and biology.

[24]  M S Patterson,et al.  Singlet oxygen luminescence as an in vivo photodynamic therapy dose metric: validation in normal mouse skin with topical amino-levulinic acid , 2005, British Journal of Cancer.

[25]  Stanley B. Brown,et al.  Fluorescence Photobleaching of ALA‐induced Protoporphyrin IX during Photodynamic Therapy of Normal Hairless Mouse Skin: The Effect of Light Dose and Irradiance and the Resulting Biological Effect , 1998, Photochemistry and photobiology.

[26]  A. Williams,et al.  Assessing and interpreting arterial blood gases and acid-base balance , 1998, BMJ.